Genotypes, serum HCV-RNA and viral loads of hepatitis C virus in the recipients before and after living donor liver transplantation (LDLT).

<p>Genotypes, serum HCV-RNA and viral loads of hepatitis C virus in the recipients before and after living donor liver transplantation (LDLT).</p

<i>IL28B</i> single nucleotide polymorphism (SNP) genotypes of rs8099917 and rs12979860 in 24 recipients with HCV-RNA clearance after living donor liver transplantation and their anti-viral treatment strategy.

<p><i>IL28B</i> single nucleotide polymorphism (SNP) genotypes of rs8099917 and rs12979860 in 24 recipients with HCV-RNA clearance after living donor liver transplantation and their anti-viral treatment strategy.</p

<i>IL28B</i> polymorphism rs12979860 allelic discrimination with 96-well microplates interpreted using 7500 Fast Real-Time Polymerase Chain Reaction System (Applied Biosystems International, Framingham, MA).

<p>Red ball represented genotype CC. Green triangle represented genotype CT.</p

PAGE analysis of BER activities of AlkA, hMPG and HeLa CFE1s for Oxa and Oxa–Sp

<p><b>Copyright information:</b></p><p>Taken from "Repair activity of base and nucleotide excision repair enzymes for guanine lesions induced by nitrosative stress"</p><p>Nucleic Acids Research 2005;33(7):2181-2191.</p><p>Published online 14 Apr 2005</p><p>PMCID:PMC1079971.</p><p>© The Author 2005. Published by Oxford University Press. All rights reserved</p> () 25OXA, 25OXA–SP and 34MG (all 2 nM, and ) were incubated with the indicated amounts of AlkA and hMPG at 37°C for 30 min. After incubation, the reaction mixture was treated with 0.1 M NaOH to cleave AP sites, and products were separated by 16% denaturing PAGE. The nicked products due to β-elimination (upper bands) and β,δ-elimination (lower bands) are indicated by open brackets. () 25OXA and 25HX (both 2 nM, and ) were incubated in hMPG buffer with the indicated amounts of HeLa CFE1s at 37°C for 1 h. Products were analyzed as described above

Clinical data of the nine living donor liver transplant recipients with recurrence of hepatocellular carcinoma.

<p>*Days from LDLT to HCC recurrence.</p><p>^#Edmondson-Steiner’s cell grading of HCC. AFP, alpha-fetoprotein; HCC, hepatocellular carcinoma; LDLT, living donor liver transplantation; MVI, microvascular invasion in the original removed liver, 66.7% (6/9); SD, standard deviation</p><p>Clinical data of the nine living donor liver transplant recipients with recurrence of hepatocellular carcinoma.</p

Results of the tests of within-subjects effects on biomarkers and time in living donor liver transplantation with hepatocellular carcinoma recurrence.

<p>^a: computed using alpha = 0.05</p><p>Results of the tests of within-subjects effects on biomarkers and time in living donor liver transplantation with hepatocellular carcinoma recurrence.</p

Statistical analysis of FGF-2, survivin, Ki67, endostatin, and VEGF levels, as measured by ELISA before (_1), early after (_2), and late after (_3) after living donor liver transplantation (LDLT).

<p>The Mann-Whitney <i>U</i> test was used to compare the differences in the biomarkers at the various time points between the recipients with and those without HCC recurrence.</p

Statistical analysis of FGF-2, survivin, Ki67, endostatin, and VEGF levels, as measured by ELISA before (_1), early after (_2), and late after (_3) after living donor liver transplantation (LDLT).

<p>The Mann-Whitney <i>U</i> test was used to compare the differences in the biomarkers at the various time points between the recipients with and those without HCC recurrence.</p

Statistical analysis of FGF-2, survivin, Ki67, endostatin, and VEGF levels, as measured by ELISA before (_1), early after (_2), and late after (_3) after living donor liver transplantation (LDLT).

<p>The Mann-Whitney <i>U</i> test was used to compare the differences in the biomarkers at the various time points between the recipients with and those without HCC recurrence.</p

Statistical analysis of FGF-2, survivin, Ki67, endostatin, and VEGF levels, as measured by ELISA before (_1), early after (_2), and late after (_3) after living donor liver transplantation (LDLT).

<p>The Mann-Whitney <i>U</i> test was used to compare the differences in the biomarkers at the various time points between the recipients with and those without HCC recurrence.</p